Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT01944332
NA

Gamete Treatment to Correct Fertilization Failure

Sponsor: Weill Medical College of Cornell University

View on ClinicalTrials.gov

Summary

In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

Key Details

Gender

All

Age Range

21 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

1200

Start Date

2007-09

Completion Date

2027-11-30

Last Updated

2025-12-17

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

gamete treatment

Patient specimen will be selected through a synthetic, sterile, single-use, culture-tested mesh. The specimen will then be placed in a 37°C environment. After 30 minutes, the selected portion is retrieved from the other side of the mesh. The spermatozoa will be prepared in the standard fashion and utilized for injection or intrauterine insemination after exposure to a membrane permeabilizing agent. Human recombinant PLC-zeta will also be used if the spermatozoa have been confirmed to be PLC-zeta deficient. The injected oocytes will then be exposed to activating agents for the purpose of inducing embryo development. The oocyte activating agent is calcium ionophore and for sperm membrane permeabilization to assist in sperm DNA decondensation is streptolysin O (SLO).

Locations (1)

Center fo Reproductive Medicine

New York, New York, United States